Briefing
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).
The PATH study used the NavDx tumor-tissue-modified viral HPV DNA score after surgery to select people with HPV-positive oropharyngeal cancer for omission or delay of adjuvant radiation.
- Design: Evidence level 1
- Assay: NavDx
International Journal of Radiation Oncology, Biology, PhysicsPubMed 41043558DOI 10.1016/j.ijrobp.2025.09.044